GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Inspiration Healthcare Group IHC.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

17.50p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2026

Revenue

£47.5m

FY2017FY2026

Net income

−£1.0m

FY2017FY2026

Free cash flow

£6.3m

FY2017FY2026

Shareholders' equity

£15.7m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue£47.5m£38.3m£37.6m£41.2m£41.0m£37.0m£17.8m£15.5m£15.5m£14.3m
Gross profit£20.1m£16.4m£17.9m£17.6m£20.2m£17.1m£8.1m£7.0m£6.8m£6.4m
Research and development£173,000£247,000£118,000£116,000£348,000£190,000£48,000£147,000£37,000£1,000
Operating income£520,000−£14.7m−£4.9m£1.5m£4.8m£4.6m£1.6m£1.2m£1.2m£954,000
Net income−£1.0m−£15.0m−£6.0m£272,000£4.2m£2.8m£733,000£1.1m£1.2m£312,000
Diluted earnings per share-0.01-0.17-0.090.000.060.040.020.040.040.01

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets£35.7m£41.1m£49.0m£54.9m£50.1m£43.2m£16.5m£8.2m£7.5m£6.4m
Cash and short-term investments£1.2m£733,000£609,000£2.3m£9.3m£10.7m£4.5m£2.5m£2.1m£2.2m
Total liabilities£20.0m£24.4m£20.0m£19.4m£14.6m£11.7m£5.9m£2.6m£3.1m£3.3m
Debt£11.8m£15.0m£12.8m£13.1m£7.5m£3.2m£558,000£319,000£328,000£16,000
Shareholders' equity£15.7m£16.6m£29.0m£35.5m£35.5m£31.6m£10.5m£5.5m£4.4m£3.1m
Shares outstanding90m90m69m68m68m69m34m31m31m31m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations£6.9m−£1.5m£2.0m−£3.5m£3.5m£4.7m£1.5m£848,000£952,000£564,000
Capital spending−£610,000−£2.0m−£1.6m−£8.3m−£4.0m−£920,000−£379,000−£101,000−£254,000−£313,000
Free cash flow£6.3m−£3.5m£380,000−£11.9m−£436,000£3.8m£1.1m£747,000£698,000£251,000
Dividends paid——−£420,000−£419,000−£412,000−£136,000−£136,000−£136,000−£136,000—

Latest quarters

By quarter end

Jul 2026Jan 2026Jul 2025Jan 2025Jul 2024Jan 2024Jul 2023Apr 2023
Revenue£22.0m£23.6m£24.0m£21.2m£17.0m£17.3m£20.4m£10.2m
Gross profit£9.2m£9.7m£11.1m£9.0m£7.4m£8.0m£9.9m£4.9m
Operating income£122,000−£580,000£233,000£88,000−£3.2m−£5.1m£556,000£278,000
Net income£170,000−£778,000−£262,000−£11.2m−£3.8m−£6.0m−£56,000−£28,000
Diluted earnings per share0.00-0.01-0.00-0.12-0.05-0.09-0.00-0.00
Cash from operations£2.0m£3.0m£3.0m—−£2.0m−£1.0m£3.0m£1.0m
Capital spending——−£1.0m−£1.0m————
Free cash flow——£2.0m—————
Total assets£36.9m£35.7m£36.7m£41.1m£51.5m£49.0m£53.1m£53.1m
Cash and short-term investments£533,000£1.2m£620,000£733,000£2.2m£609,000£1.9m£1.9m
Debt£6.2m£6.7m£1.5m£9.6m£9.6m£7.4m£4.8m—
Shareholders' equity£15.9m£15.7m£16.4m£16.6m£28.0m£29.0m£35.2m£32.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.9%5.2%14.5%
Operating income-29.6%-35.3%0.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin42.5%43.7%45.1%45.0%
Operating margin-16.5%-10.7%-3.4%-0.9%
Net margin-18.7%-13.2%-6.1%-3.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-15.1-0.9-1.454.95.216.720.810.48.930.2
Price to sales0.30.30.20.40.51.30.90.70.70.7

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 23 Nov 2023.

FY2024FY2023FY2022FY2021
Paid in the year0.0060.0060.0060.002
  • 10-to-1 reverse split · 24 Jun 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.